Uridine-Modified Ruthenium(II) Complex as Lysosomal LIMP-2 Targeting Photodynamic Therapy Photosensitizer for the Treatment of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Uridine-Modified Ruthenium(II) Complex as Lysosomal LIMP-2 Targeting Photodynamic Therapy Photosensitizer for the Treatment of Triple-Negative Breast Cancer

Published:2024-02-16 Issue:3 Volume:4 Page:1081-1096
ISSN:2691-3704
Container-title:JACS Au
language:en
Short-container-title:JACS Au

Author:

Wu Qiong¹²,Yuan Chanling¹,Wang Jiacheng¹,Li Guohu¹,Zhu Chunguang¹,Li Li¹,Wang Zongtao¹,Lv Qingshuang¹,Mei Wenjie¹^ORCID

Affiliation:

1. School of Pharmacy, Guangdong Engineering Technology Research Centre of Molecular Probe and Biomedicine Imaging, Guangdong Pharmaceutical University, Guangzhou 510006, China

2. Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou 530316, China

Funder

Science and Technology Planning Project of Guangdong Province

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Provincial Major Scientific Research Projects at Universities of Guangdong Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/jacsau.3c00808

Reference67 articles.

1. Photodynamic therapy for cancer

2. Taking phototherapeutics from concept to clinical launch

3. MCOLN1 is a ROS sensor in lysosomes that regulates autophagy

4. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

5. Signals from the lysosome: a control centre for cellular clearance and energy metabolism

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria-localizing triphenylphosphine-8-hydroxyquinoline Ru complexes induce ferroptosis and their antitumor evaluation;Journal of Inorganic Biochemistry;2024-08

2. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024